Farther Finance Advisors’s MaxCyte MXCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.56K Buy
1,263
+753
+148% +$750 ﹤0.01% 5244
2026
Q1
$379 Buy
510
+370
+264% +$345 ﹤0.01% 5329
2025
Q4
$217 Hold
140
﹤0.01% 5202
2025
Q3
$221 Sell
140
-11,672
-99% -$20.3K ﹤0.01% 4699
2025
Q2
$25.8K Buy
11,812
+11,665
+7,935% +$28.2K ﹤0.01% 2528
2025
Q1
$398 Sell
147
-70
-32% -$276 ﹤0.01% 3815
2024
Q4
$903 Hold
217
﹤0.01% 3286
2024
Q3
$844 Hold
217
﹤0.01% 3292
2024
Q2
$831 Hold
217
﹤0.01% 3134
2024
Q1
$909 Hold
217
﹤0.01% 2812
2023
Q4
$1.02K Buy
+217
New +$845 ﹤0.01% 2724

Other funds holding MXCT

Farther Finance Advisors's MXCT Position: Q2 2026 in Review

Farther Finance Advisors increased its MaxCyte (MXCT) stake by 148% in Q2 2026, buying an estimated $750 and bringing the position to 1,263 shares worth $1.56K. The position accounts for ﹤0.01% of the portfolio, ranked #5244.

Farther Finance Advisors first reported a position in MXCT in Q4 2023 and has held it in 11 quarters since. The position peaked at $25.8K in Q2 2025. 19 funds tracked by Wall St. Rank hold MXCT as of Q2 2026.

  • Farther Finance Advisors held 1,263 shares of MaxCyte worth $1.56K as of Q2 2026.
  • Farther Finance Advisors bought 753 MaxCyte shares in Q2 2026, an estimated $750.
  • MaxCyte made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5244 holding.
  • Farther Finance Advisors first reported a position in MaxCyte in Q4 2023 and has held it in 11 quarters since.
  • Farther Finance Advisors's MaxCyte position peaked at $25.8K in Q2 2025.
  • 19 funds tracked by Wall St. Rank held MaxCyte as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.